Search For

The emerging role of GLP-1 receptor agonists in treating or preventing cancer

Breast cancer cell resistance to hormonal and targeted therapeutics is correlated with the inactivation of the NR6A1 axis

Mechanism of ferroptosis resistance in cancer cells

HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond

Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity

Fra-1 affects chemotherapy sensitivity by inhibiting ferroptosis in gastric cancer cells

The role and clinical applications of exosomes in cancer drug resistance

Exploring resistance to immune checkpoint inhibitors and targeted therapies in melanoma

NFE2L2 and ferroptosis resistance in cancer therapy

The BET inhibitor sensitivity is associated with the expression level of CDC25B in pancreatic cancer models

Unlocking the potential of immunotherapy in platinum-resistant ovarian cancer: rationale, challenges, and novel strategies

Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancers